Target intelligence / Profile preview

FIC domain-containing protein (FICD) (FICD)

Target
FICD
Molecular classification
Enzyme, Adenylyltransferase, AMPylase, De-AMPylase
01

Overview

FIC domain-containing protein (FICD), also known as HYPE, is a bifunctional enzyme localized in the endoplasmic reticulum (ER) that serves as a critical regulator of protein homeostasis. It catalyzes both the addition (AMPylation) and removal (de-AMPylation) of an adenosine monophosphate (AMP) moiety from the ER-resident chaperone BiP (HSPA5), thereby acting as a molecular rheostat for the unfolded protein response (UPR). Under low-stress conditions, FICD AMPylates BiP to maintain a reserve of inactive chaperones, while ER stress triggers FICD to de-AMPylate BiP, acutely increasing the pool of active chaperones to assist in protein folding. Dysregulation of FICD activity is linked to various pathologies, including neurodegenerative disorders like hereditary spastic paraplegia and metabolic conditions such as neonatal diabetes. Recent drug discovery efforts have identified small-molecule inhibitors, such as C22 and C73, which target FICD to modulate UPR signaling and improve protein folding in disease contexts.

Other names
HYPEHuntingtin yeast-interacting protein EHIP13HIP-13Protein adenylyltransferase FICDAMPylaseDe-AMPylase FICDAdenosine monophosphate-protein transferase FICD
02

Mechanism of action

Inhibition of FICD-mediated AMPylation or de-AMPylation of the ER chaperone BiP (HSPA5) to modulate unfolded protein response (UPR) signaling and restore proteostasis.

03

Biological functions

Protein AMPylationProtein de-AMPylationUnfolded protein response (UPR) regulationProteostasisEndoplasmic reticulum stress responseNeurogenesis
04

Disease associations

Neurodegenerative diseaseMetabolic diseaseCancerCardiovascular disease
05

Safety considerations

Potential for maladaptive ER stress if de-AMPylation is excessively inhibitedImpact on protein folding in high-demand secretory cells like pancreatic beta cellsTissue-specific consequences of UPR modulation
06

Interacting drugs

C22

4 more in the full profile.

07

Biomarkers

BiP AMPylation levels (Thr518)UPR activation markers (IRE1, PERK, ATF6)Proinsulin secretion levels

Beyond the preview

Go deeper on FIC domain-containing protein (FICD) (FICD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FIC domain-containing protein (FICD) (FICD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call